DJIA 17,367.17 171.75 1.00%
NASDAQ 4,628.12 61.98 1.36%
S&P 500 2,013.43 18.78 0.94%
market minute promo

Pfizer (NYSE: PFE)

29.95 0.11 (0.35%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $29.95 0.35%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.01
Previous Close $29.84
Daily Range $29.94 - $30.20
52-Week Range $27.51 - $32.96
Market Cap $189.9B
P/E Ratio 17.35
Dividend (Yield) $1.04 (3.5%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
12/02/14
Volume 12,468,360
Average Daily Volume 28,545,605
Current FY EPS $2.25

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off

Pfizer's third-quarter earnings report points to strength in emerging markets and select segments of its business, but also lends to the reality that a turnaround could be a long time coming.

PFE Crosses Above Key Moving Average Level

The Importance of Capital Intensity and Thoughts From Einhorn

Pfizer's Trumenba Gains Accelerated Approval in the U.S. - Analyst Blog

Johnson & Johnson Fairly Valued - I Will Bet on It

How Cash-Rich Companies Might Repatriate Foreign Profits Tax-Free, Liberating The Nation From Politi

How Cash-Rich Companies Might Repatriate Foreign Profits Tax-Free, Liberating The Nation From Political Gridlock At The Same Time

Buybacks-Driven Market: Engineered Too Far?

3 Stocks Reiterated As A Buy: PFE, MRK, WFC

Pfizer meningitis vaccine wins U.S. approval- FDA

Stock Market News for October 29, 2014 - Market News

Pfizer Earnings Were Not Impressive

See More PFE News...

PFE's Top Competitors

PFE $29.95 (0.35%)
Current stock: PFE
JNJ $107.43 (0.36%)
Current stock: JNJ
ROG $68.11 (1.38%)
Current stock: ROG
GSK $45.41 (0.60%)
Current stock: GSK